Infosys Ties up with ValGenesis to Further Enable Digitisation in Life Sciences | CORPORATE ETHOS

Infosys Ties up with ValGenesis to Further Enable Digitisation in Life Sciences

By: | January 5, 2018

Jan 5: Tech major Infosys on Thursday announced a new partnership with leading paperless validation company ValGenesis, that will bring even stronger compliance and quality management for its customers in the healthcare and life sciences sectors.

“Under the partnership, Infosys will integrate ValGenesis’ Validation Lifecycle Management System (VLMS) within its suite of services for the pharmaceutical and biotech industry, which will be delivered in a rapidly deployable, highly secure cloud environment,” the company said.

According to the company, the VLMS efficiently manages all types of validation activities such as equipment, computer systems, cleaning, analytical methods, and process validation. The system delivers technology solutions that are fully configurable and rapidly deployable onsite or by way of a secured cloud environment.

Commentng on the development, Sangita Singh, Executive Vice President and Head, Healthcare & Lifesciences, Infosys, said, “healthcare is potentially the world’s most stringently-regulated industry. The digitization of the industry to ensure better data and document accuracy is incredibly important for many ethical, legal and business reasons, with auditors and regulators demanding that data regarding equipment, computer systems, processes, and outcomes be properly recorded and validated. ValGenesis is pioneering paperless validation, and our new partnership will bring significant savings and much better compliance to our customers.”

Shares of the company were trading at Rs 1,020.60, up 0.52% from the previous closing of Rs 1,015.30, on BSE at 10.47 am on Friday.